Natco Pharma Q1 net, revenue slump on lower cancer drug sales
Decline largely attributable to Lenalidomide revenue, generic drugmaker said as its shares tumbled more than 5%
· 8/14/2026, 12:41:45 PM· 2 min read
Decline largely attributable to Lenalidomide revenue, generic drugmaker said as its shares tumbled more than 5%
Read original story →Related stories
business
Electric vehicle sales targets could be cut after pressure from car makers
business
RIL, Rolls-Royce in JV to develop combat engine; plans Aerospace Gas Turbine Complex
business
Rupee gains 3 paise to 95.42 against U.S. dollar
business